Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.140
+0.020 (0.64%)
Oct 11, 2024, 4:00 PM EDT - Market closed
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $1.09 billion as of October 11, 2024. Its market cap has decreased by -68.31% in one year.
Market Cap
1.09B
Enterprise Value
1.29B
1-Year Change
-68.31%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since the IPO on February 5, 2015, Evotec SE's market cap has increased from $464.70M to $1.09B, an increase of 135.62%. That is a compound annual growth rate of 9.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 11, 2024 | 1.11B | -73.23% |
Dec 29, 2023 | 4.16B | 45.19% |
Dec 30, 2022 | 2.86B | -65.68% |
Dec 31, 2021 | 8.34B | 108.85% |
Dec 31, 2020 | 3.99B | 42.78% |
Dec 31, 2019 | 2.80B | 29.06% |
Dec 31, 2018 | 2.17B | 24.07% |
Dec 29, 2017 | 1.75B | 106.15% |
Dec 30, 2016 | 847.40M | 72.48% |
Dec 31, 2015 | 491.30M | 5.72% |
Feb 5, 2015 | 464.70M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ANI Pharmaceuticals | 1.12B |
Establishment Labs Holdings | 1.11B |
Relay Therapeutics | 1.10B |
Autolus Therapeutics | 1.10B |
Calliditas Therapeutics AB | 1.10B |
Artivion | 1.09B |
Evolus | 1.07B |
Pharvaris | 1.07B |